Staff Profile
Dr Linda Hogarth
缅北禁地 Cancer Centre Project Manager
- Email: linda.hogarth@ncl.ac.uk
- Telephone: +44 (0) 191 213 8454
- Fax: +44 (0) 191 213 7430
- Address: Sir Bobby Robson Cancer Trials Research Centre, Freeman Hospital, Freeman Road, 缅北禁地 upon Tyne NE7 7DN
Qualifications:
Postgraduate Certificate in Clinical research 2012
PhD 1999
FIMLS (in clinical chemistry) 1988
BSc Hons (Biochemistry 1983
Current position:
缅北禁地 Cancer Centre (NCC) Project Coordinator Jul 2013-present
Previous Positions:
Tissue Banking and Trials Coordinator- Sir Bobby Robson Cancer Trials Centre Oct 2010-Jun 2013
Clinical Trials Coordinator/Lab Supervisor- Sir Bobby Robson Cancer Trials Centre Apr 2010-Sep 2010
Senior Research Associate - Leukaemia Research Group, 缅北禁地Jan 2002- Mar 2010
Research Associate - Leukaemia Research Group, 缅北禁地 Apr1990-Dec 2001
Medical Laboratory Scientific Officer Oct 1983 - Mar 1990
Current research:
Management of translational research studies in patients with solid tumours
Previous research:
Factors influencing the metabolism and efficacy of thiopurine drugs
Cell cycle de-regulation in acute lymphoblastic leukaemia
Drug resistance mechanisms in acute lymphoblastic leukaemia
- Greystoke A, Hogarth L, Patterson M, Williams I, Ness T, Georgiadis K, Bolt L, Bettison I, Turner D, Jamieson D, Simmons T, Hughes A, Jaedicke K, Gardiner J, Mulvenna P, Leaning D, Bradshaw A, Butler R, Black F. . In: 14th Annual British Thoracic Oncology Group Conference 2016. 2016, Dublin, Ireland: Elsevier.
- Davies C, Hogarth LA, Mackenzie KL, Hall AG, Lock RB. . Cell Cycle 2015, 14(22), 3602-3612.
- Deva S, Baird RD, Cresti N, Garcia-Corbacho J, Hogarth L, Frenkel EP, Kawaguchi K, Arimura A, Donaldson K, Posner J, Sarker D, Jodrell DI, Plummer R, Spicer JF. . In: ASCO Annual Meeting. 2015, Chicago, Illinois, USA: American Society of Clinical Oncology.
- Coulthard SA, Redfern CPF, Vikingsson S, Lindqvist-Appell M, Skoglund K, Jakobsen-Falk I, Hall AG, Taylor GA, Hogarth LA. . Molecular Cancer Therapeutics 2011, 10(3), 495-504.
- Davies C, Hogarth LA, Dietrich PA, Bachmann PS, Mackenzie KL, Hall AG, Lock RB. . Journal of Biological Chemistry 2011, 286(43), 37639-37650.
- Irving JAE, Bloodworth LC, Bown NP, Case MC, Hogarth LA, Hall AG. . Cancer Research 2005, 65(8), 3053-3058.
- Coulthard SA, Hogarth LA. . Investigational New Drugs 2005, 23(6), 523-532.
- Coulthard SA, Matheson EC, Hall AG, Hogarth LA. . In: Joint 11th International and 9th European Symposium on Purines and Pyrimidines. 2004, Man Egmond Aan Zee, Netherlands: Nucleosides, Nucleotides and Nucleic Acids: Taylor & Francis Inc.
- Coulthard, S.A., Hogarth, L.A., Little, M.A., Matheson, E., Redfern, C.P.F., Minto, C.L.J., Hall, A.G. . Molecular Pharmacology 2002, 62(1), 102-109.
- Hogarth LA, Hall AG. . Blood 1999, 93(8), 2671-2678.
- Hogarth LA, English M, Price L, Wyllie R, Pearson ADJ, Hall AG. . Cancer Chemotherapy and Pharmacology 1996, 37(5), 479-485.
- Wyatt N, Hogarth L, Turner D, Patterson M, Jamieson D, Black F, Hutton C, Mulvenna P, Simmons T, Bradshaw A, Kolenda C, Parker C, Martin-Ruiz C, Greystoke A. . In: IASLC 17th World Conference on Lung Cancer. 2016, Vienna, Austria: Elsevier.